Daito Pharmaceutical Co (TSE:4577) ROCE %: 5.36% (As of Nov. 2025)

What is Daito Pharmaceutical Co ROCE %?

Daito Pharmaceutical Co TSE:4577 -1.37% 72 ROCE % is 5.36% as of Nov. 2025. GuruFocus rates TSE:4577 with a GF Score™ of 72/100 and a GF Value™ of 円1,276.34 (Fairly Valued). The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Daito Pharmaceutical Co's annualized ROCE % for the quarter that ended in Nov. 2025 was 5.36%.

Daito Pharmaceutical Co (TSE:4577) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Daito Pharmaceutical Co ROCE % Related Terms

Daito Pharmaceutical Co ROCE % Historical Data

* Premium members only.

The historical data trend for Daito Pharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daito Pharmaceutical Co ROCE % Chart

Daito Pharmaceutical Co Annual Data

Trend

May16

May17

May18

May19

May20

May21

May22

May23

May24

May25

ROCE %

Get a 7-Day Free Trial

13.99

14.06

9.60

7.45

5.13

Daito Pharmaceutical Co Quarterly Data
	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25	May25	Aug25	Nov25	Feb26
ROCE %	Get a 7-Day Free Trial															3.65	3.84	7.10	5.36	9.79

72GF Score

Daito Pharmaceutical Co Ltd TSE:4577

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Daito Pharmaceutical Co ROCE % Calculation

Daito Pharmaceutical Co's annualized ROCE % for the fiscal year that ended in May. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: May. 2025 )		(A: May. 2024 )		(A: May. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: May. 2025 )		(A: May. 2024 )		(A: May. 2025 )
	=	3081	/	( ( (77708 - 18505)	+	(78004 - 17049) )	/ 2 )
	=	3081	/	( (59203	+	60955)	/ 2 )
	=	3081	/	60079
	=	5.13 %

Daito Pharmaceutical Co's ROCE % of for the quarter that ended in Nov. 2025 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Nov. 2025 )		(Q: Aug. 2025 )		(Q: Nov. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Nov. 2025 )		(Q: Aug. 2025 )		(Q: Nov. 2025 )
	=	3252	/	( ( (78838 - 17709)	+	(76842 - 16551) )	/ 2 )
	=	3252	/	( ( 61129	+	60291 )	/ 2 )
	=	3252	/	60710
	=	5.36 %

(1) Note: The EBIT data used here is four times the quarterly (Nov. 2025) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 5.36% mean?

Daito Pharmaceutical Co (TSE:4577) has a ROCE % of 5.36% as of Nov. 2025.

Is Daito Pharmaceutical Co's ROCE % too high?

Daito Pharmaceutical Co's current ROCE % is 5.36%. The Drug Manufacturers industry median ROCE % is 7.00. Daito Pharmaceutical Co's value of 5.36% is 23.4% below this industry median. Overall, Daito Pharmaceutical Co has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Daito Pharmaceutical Co's ROCE % compare to ZTS?

Daito Pharmaceutical Co's ROCE % of 5.36% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.00. Daito Pharmaceutical Co's value of 5.36% is 23.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Drug Manufacturers company?

The median ROCE % among Drug Manufacturers companies is 7.00, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Daito Pharmaceutical Co's current ROCE % of 5.36% is 23.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Daito Pharmaceutical Co's current ROCE % is 5.36%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Daito Pharmaceutical Co stock overvalued right now?

Based on GuruFocus' analysis, Daito Pharmaceutical Co (TSE:4577) is currently considered Fairly Valued. The stock's GF Value™ is 円1,276.34, compared to a current price of 円1,224.00 — trading 4.1% below its estimated fair value. The current ROCE % is 5.36% and 23.4% below the Drug Manufacturers industry median of 7.00. Daito Pharmaceutical Co's overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Daito Pharmaceutical Co (TSE:4577), the current ROCE % is 5.36% as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Daito Pharmaceutical Co (TSE:4577) Overvalued in 2026?

Based on GuruFocus' analysis, Daito Pharmaceutical Co stock appears to be undervalued. The current stock price of 円1,224.00 is trading 4.1% below its estimated GF Value™ of 円1,276.34. GuruFocus considers Daito Pharmaceutical Co to be Fairly Valued.

Key valuation signals for TSE:4577:

ROCE %: 5.36%
GF Value™: 円1,276.34 vs. price of 円1,224.00 (4.1% below fair value)
GF Score™: 72/100 with 3 warning signs
Industry Position: 23.4% below the Drug Manufacturers median

No single metric tells the full story. See the TSE:4577 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Daito Pharmaceutical Co Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies TSE:9273 TSE:4595 TSE:2929 TSE:4538 TSE:4574 TSE:4512 TSE:4524 TSE:4554 TSE:4597 TSE:4892 XTER:MRK TSE:4502 XSWX:GALD SHSE:600276 NSE:SUNPHARMA XTAE:TEVA LSE:HLN XSWX:SDZ ZTS HKSE:03692

Address 326 Yokamachi, Toyama, JPN, 939-8567

Website http://www.daitonet.co.jp

Daito Pharmaceutical Co Ltd is engaged in the research and development of pharmaceutical products. The company also undertakes contract manufacturing.

72GF Score

Get the complete analysis for TSE:4577

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,224.00

Price

円1,276.34

GF Value

View TSE:4577 Analysis

See ROCE % data for all stocks →